Filing Flows › Autolus Therapeutics (AUTL) › How it makes money
How Autolus Therapeutics (AUTL) makes money
Autolus Therapeutics (AUTL) made $45.7M of revenue in the second quarter 2026 (Q2 2026), +118% from a year earlier. Product revenue, net brought in $45.7M (100%); License revenue brought in $17K (0%).
Drawing the Sankey…
Revenue by segment, Q2 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Product revenue, net | $45.7M | 100.0% | — | +118% |
| License revenue | $17K | 0.0% | — | — |
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $45.7M | 100.0% |
| Income tax | $465K | 1.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $45.7M | +118% |
| Q1 2026 | $26.2M | +192% |
| Q4 2025 | $24.3M | 838× |
| Q3 2025 | $21.2M | — |
| Q2 2025 | $20.9M | — |
| Q1 2025 | $9.0M | -11% |
| Q4 2024 | $29K | — |
From Autolus Therapeutics' 10-Q filed Aug 11, 2026 (on EDGAR).
Questions
How does Autolus Therapeutics make money?
Autolus Therapeutics (AUTL) made $45.7M of revenue in the second quarter 2026 (Q2 2026), +118% from a year earlier. Product revenue, net brought in $45.7M (100%); License revenue brought in $17K (0%).
What is Autolus Therapeutics' biggest business?
Product revenue, net: $45.7M in the second quarter 2026, 100% of revenue, +118% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.